DL
Durin Life Sciences, Inc.
SEC filingBiotechnology · Stratford, NJ
Amount raised$6.2Msold at filing
Total offering$10M$3.8M still open
Investors in the raise2count reported to the SEC
FiledJul 21, 2025first sale Oct 17, 2023
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Maribeth BluyusExecutive Officer
Robert NageleDirector
Rene ChazeDirector
Executive officers, directors and promoters as listed on the Form D.